Carcinogenesis Advance Access originally published online on January 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 5, 713-722,
May 2004
Carcinogenesis vol.25 no.5 © Oxford University Press 2004; all rights reserved.
ARTICLE |
Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin
1 College of Pharmacy and 2 Department of Obstetrics and Gynecology, College of Medicine, Seoul National University, Seoul, Korea
3 To whom correspondence should be addressed Email: surh{at}plaza.snu.ac.kr
Celecoxib, the first US FDA-approved selective cyclooxygenase-2 (COX-2) inhibitor initially developed for the treatment of adult rheumatoid arthritis and osteoarthritis, was reported to reduce the polyp burden in patients with familial adenomatous polyposis. This specific COX-2 inhibitor also protects against experimentally induced carcinogenesis, but molecular mechanisms underlying its chemopreventive activities remain largely unresolved. In the present work, we found that celecoxib inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced expression of COX-2 in female ICR mouse skin when applied topically 30 min prior to TPA as determined by both immunoblot and immunohistochemical analyses. In another study, celecoxib attenuated the DNA binding activity of activator protein 1 (AP-1) through suppression of c-Jun and c-Fos expression in TPA-treated mouse skin. In addition, celecoxib inhibited both the catalytic activity and phosphorylation of p38 mitogen-activated protein (MAP) kinase. In the same animal model, TPA treatment resulted in rapid activation via phosphorylation of extracellular signal-regulated protein kinase (ERK)1/2 and p38 MAP kinase, which are upstream of AP-1 in mouse skin. In order to clarify the roles of p38 and ERK in TPA-induced AP-1 activation, we utilized the pharmacologic inhibitors of these enzymes. The p38 inhibitor SB203580 blocked TPA-mediated AP-1 activation, while the MEK1/2 inhibitor U0126 was not inhibitory despite suppression of c-Fos expression in mouse skin. Furthermore, SB203580 markedly inhibited COX-2 expression induced by TPA. Taken together, these findings suggest that celecoxib down-regulates COX-2 by blocking activation of p38 MAP kinase and AP-1, which may represent molecular mechanisms underlying antitumor promoting effects of this drug on mouse skin tumorigenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-S. Lai, S. Li, C.-Y. Chai, C.-Y. Lo, C.-T. Ho, Y.-J. Wang, and M.-H. Pan Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3',4'-hexamethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice Carcinogenesis, December 1, 2007; 28(12): 2581 - 2588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-C. Lee, J. K. Kundu, D.-M. Hwang, H.-K. Na, and Y.-J. Surh Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-{kappa}B and AP-1: I{kappa}B kinase and c-Jun-N-terminal kinase as respective potential upstream targets Carcinogenesis, July 1, 2007; 28(7): 1491 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zhang, J. Li, K. Wu, W. Ouyang, J. Ding, Z.-g. Liu, M. Costa, and C. Huang JNK1, but not JNK2, is required for COX-2 induction by nickel compounds Carcinogenesis, April 1, 2007; 28(4): 883 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-A. PARK, E.-H. KIM, H.-K. NA, and Y.-J. SURH KG-135 Inhibits COX-2 Expression by Blocking the Activation of JNK and AP-1 in Phorbol Ester-Stimulated Human Breast Epithelial Cells Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 545 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Kundu, Y. K. Shin, S. H. Kim, and Y.-J. Surh Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-{kappa}B in mouse skin by blocking I{kappa}B kinase activity Carcinogenesis, July 1, 2006; 27(7): 1465 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Lee, J. K. Kundu, S. O. Kim, K.-S. Chun, H. J. Lee, and Y.-J. Surh Cocoa Polyphenols Inhibit Phorbol Ester-Induced Superoxide Anion Formation in Cultured HL-60 Cells and Expression of Cyclooxygenase-2 and Activation of NF-{kappa}B and MAPKs in Mouse Skin In Vivo J. Nutr., May 1, 2006; 136(5): 1150 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Frey, A. Golovin, and D. B. Polk Epidermal Growth Factor-stimulated Intestinal Epithelial Cell Migration Requires Src Family Kinase-dependent p38 MAPK Signaling J. Biol. Chem., October 22, 2004; 279(43): 44513 - 44521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Shishodia, D. Koul, and B. B. Aggarwal Cyclooxygenase (COX)-2 Inhibitor Celecoxib Abrogates TNF-Induced NF-{kappa}B Activation through Inhibition of Activation of I{kappa}B{alpha} Kinase and Akt in Human Non-Small Cell Lung Carcinoma: Correlation with Suppression of COX-2 Synthesis J. Immunol., August 1, 2004; 173(3): 2011 - 2022. [Abstract] [Full Text] [PDF]
|
|